Overall, germline BRCA1 mutated cancers had significantly higher cyclin E1 protein than the BRCA1 wildtype cases, and tumors with other breast cancer associated germline mutations (BRCA2, PALB2, or CHEK2) (Fig. 1b). The gene discussed is BRCA1; the disease is breast carcinoma.